Sarepta Therapeutics (SRPT) EPS (Diluted) Growth (5y) (2015 - 2026)
Sarepta Therapeutics (SRPT) EPS (Diluted) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.89% |
| Dec 31, 2025 | -3.07% |
| Sep 30, 2025 | 6.43% |
| Jun 30, 2025 | 24.20% |
| Mar 31, 2025 | -82.21% |
| Dec 31, 2024 | 19.72% |
| Sep 30, 2024 | 17.04% |
| Jun 30, 2024 | 15.08% |
| Mar 31, 2024 | 18.59% |
| Dec 31, 2023 | 17.41% |
| Sep 30, 2023 | 16.78% |
| Jun 30, 2023 | 30.54% |
| Mar 31, 2023 | -60.68% |
| Dec 31, 2022 | 64.58% |
| Sep 30, 2022 | -419.25% |
| Jun 30, 2022 | -370.54% |
| Mar 31, 2022 | -281.09% |
| Dec 31, 2021 | 4.72% |
| Sep 30, 2021 | -245.21% |
| Jun 30, 2021 | 5.43% |